Insider Trading27 May 2026, 07:31 pm
Goldline Pharma: Trading Window Closure from May 19, 2026
AI Summary
Goldline Pharmaceutical Ltd announced the closure of its trading window for designated persons and their immediate relatives from May 19, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and pertains to the consideration of audited financial results for the half year and year ended March 31, 2026. The trading window will remain closed until 48 hours after the declaration of the aforementioned financial results. The date of the board meeting to consider the results will be intimated separately.
Key Highlights
- Trading window closes May 19, 2026 for insiders.
- Closure relates to audited financial results consideration.
- Results are for half year and year ended March 31, 2026.
- Window reopens 48 hours post results declaration.
- Board meeting date for results will be announced later.